Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Thoracic Surgery

  Free Subscription

Articles published in Thromb Haemost

Retrieve available abstracts of 37 articles:
HTML format

Single Articles

    May 2021
  1. COLE O
    Atrial Fibrillation After Cardiac Surgery - To Infinity and Beyond!
    Thromb Haemost. 2021 May 11. doi: 10.1055/a-1506-8744.
    PubMed     Abstract available

    March 2021
  2. FABRIS E, Korjian S, Coller B, Ten Berg JM, et al
    Pre-Hospital Antiplatelet Therapy for STEMI Patients Undergoing Primary Percutaneous Coronary Intervention: What We Know and What Lies Ahead.
    Thromb Haemost. 2021 Mar 7. doi: 10.1055/a-1414-5009.
    PubMed     Abstract available

    February 2021
  3. HOFER F, Hammer A, Steininger M, Kazem N, et al
    The Prognostic Potential of Atrial Natriuretic Peptide on the Development of Post-Operative Atrial Fibrillation after Cardiac Surgery.
    Thromb Haemost. 2021 Feb 25. doi: 10.1055/a-1400-6096.
    PubMed     Abstract available

    December 2020
  4. AZNAOURIDIS K, Tselegkidi ME, Kanakakis I, Alexopoulos D, et al
    Dual Antithrombotic Therapy in Atrial Fibrillation Patients undergoing Percutaneous Coronary Angioplasty: The Impact of Bleeding Risk Score on Outcome.
    Thromb Haemost. 2020 Dec 30. doi: 10.1055/s-0040-1721777.

  5. LAINE M, Panagides V, Frere C, Cuisset T, et al
    On-ticagrelor platelet reactivity and clinical outcome in patients undergoing percutaneous coronary intervention for acute coronary syndrome.
    Thromb Haemost. 2020 Dec 1. doi: 10.1055/a-1326-5110.
    PubMed     Abstract available

    November 2020
  6. MONTALTO C, Ferlini M, Casula M, Mandurino-Mirizzi A, et al
    DAPT Score to Stratify Ischemic and Bleeding Risk after Percutaneous Coronary Intervention: An Updated Systematic Review, Meta-Analysis, and Meta-Regression of 100,211 Patients.
    Thromb Haemost. 2020 Nov 19. doi: 10.1055/s-0040-1721145.

    October 2020
  7. ZHENG YY, Wu TT, Gao Y, Guo QQ, et al
    A Novel ABC Score Predicts Mortality in Non-ST-Segment Elevation Acute Coronary Syndrome Patients Who underwent Percutaneous Coronary Intervention.
    Thromb Haemost. 2020 Oct 31. doi: 10.1055/s-0040-1718411.
    PubMed     Abstract available

    August 2020
  8. LOTHER A, Kaier K, Ahrens I, Bothe W, et al
    Bleeding Complications Drive In-Hospital Mortality of Patients with Atrial Fibrillation after Transcatheter Aortic Valve Replacement.
    Thromb Haemost. 2020 Aug 22. doi: 10.1055/s-0040-1715833.
    PubMed     Abstract available

    July 2020
  9. MATSUSHITA K, Marchandot B, Trimaille A, Kibler M, et al
    Paradoxical Increase of Stroke in Patients with Defect of High Molecular Weight Multimers of the von Willebrand Factors following Transcatheter Aortic Valve Replacement.
    Thromb Haemost. 2020 Jul 29. doi: 10.1055/s-0040-1713424.
    PubMed     Abstract available

  10. LIU Z, Tian R, Wang Y, Chen Q, et al
    Platelet Inhibition with Ticagrelor versus Clopidogrel in Diabetic Patients after Percutaneous Coronary Intervention for Chronic Coronary Syndromes.
    Thromb Haemost. 2020 Jul 15. doi: 10.1055/s-0040-1713375.
    PubMed     Abstract available

    June 2020
  11. KAZEM N, Sulzgruber P, Thaler B, Baumgartner J, et al
    CD8+CD28null T Lymphocytes are Associated with the Development of Atrial Fibrillation after Elective Cardiac Surgery.
    Thromb Haemost. 2020 Jun 28. doi: 10.1055/s-0040-1713096.
    PubMed     Abstract available

    February 2020
  12. GOROG DA, Geisler T
    Platelet Inhibition in Acute Coronary Syndrome and Percutaneous Coronary Intervention: Insights from the Past and Present.
    Thromb Haemost. 2020 Feb 19. doi: 10.1055/s-0040-1702920.
    PubMed     Abstract available

    January 2020
  13. WALDEN K, Jeppsson A, Nasic S, Karlsson M, et al
    Fibrinogen Concentrate to Cardiac Surgery Patients with Ongoing Bleeding does not Increase the Risk of Thromboembolic Complications or Death.
    Thromb Haemost. 2020 Jan 15. doi: 10.1055/s-0039-3402759.
    PubMed     Abstract available

    October 2019
  14. GEISLER T, Jorbenadze R, Popov AF, Mueller KL, et al
    Thrombogenicity and Antithrombotic Strategies in Structural Heart Interventions and Nonaortic Cardiac Device Therapy-Current Evidence and Practice.
    Thromb Haemost. 2019;19:1590-1605.
    PubMed     Abstract available

    May 2019
  15. UBAID S, Ford TJ, Berry C, Murray HM, et al
    Cangrelor versus Ticagrelor in Patients Treated with Primary Percutaneous Coronary Intervention: Impact on Platelet Activity, Myocardial Microvascular Function and Infarct Size: A Randomized Controlled Trial.
    Thromb Haemost. 2019 May 26. doi: 10.1055/s-0039-1688789.
    PubMed     Abstract available

  16. KANG J, Park KW, Ki YJ, Park J, et al
    Development and Validation of an Ischemic and Bleeding Risk Evaluation Tool in East Asian Patients Receiving Percutaneous Coronary Intervention.
    Thromb Haemost. 2019 May 12. doi: 10.1055/s-0039-1688792.
    PubMed     Abstract available

    April 2019
  17. PASTORI D, Eikelboom JW, Anand SS, Patel MR, et al
    Management of Patients with Asymptomatic and Symptomatic Carotid Artery Disease: Update on Anti-Thrombotic Therapy.
    Thromb Haemost. 2019;119:576-585.
    PubMed     Abstract available

    March 2019
  18. ZHENG YY, Wu TT, Chen Y, Hou XG, et al
    Gamma-Glutamyl Transferase-to-Platelet Ratio as a Novel Predictor of Long-Term Adverse Outcomes in Patients after Undergoing Percutaneous Coronary Intervention: A Retrospective Cohort Study.
    Thromb Haemost. 2019 Mar 1. doi: 10.1055/s-0039-1681103.
    PubMed     Abstract available

    January 2019
  19. VON ZUR MUHLEN C, Bothe W, Bode C
    The Optimal Anti-Thrombotic Regimen after Surgical Bioprosthetic Aortic Valve Replacement-Does it Really Matter?
    Thromb Haemost. 2019 Jan 8. doi: 10.1055/s-0038-1677504.

  20. AN KR, Belley-Cote EP, Um KJ, Gupta S, et al
    Antiplatelet Therapy versus Anticoagulation after Surgical Bioprosthetic Aortic Valve Replacement: A Systematic Review and Meta-Analysis.
    Thromb Haemost. 2019 Jan 7. doi: 10.1055/s-0038-1676816.
    PubMed     Abstract available

    December 2018
  21. TSCHARRE M, Vogel B, Tentzeris I, Freynhofer MK, et al
    Prognostic Impact of Soluble P-Selectin on Long-Term Adverse Cardiovascular Outcomes in Patients Undergoing Percutaneous Coronary Intervention.
    Thromb Haemost. 2018 Dec 28. doi: 10.1055/s-0038-1676563.
    PubMed     Abstract available

    October 2018
  22. SORRENTINO S, Baber U, Claessen BE, Camaj A, et al
    Determinants of Significant Out-Of-Hospital Bleeding in Patients Undergoing Percutaneous Coronary Intervention.
    Thromb Haemost. 2018 Oct 12. doi: 10.1055/s-0038-1673687.
    PubMed     Abstract available

  23. GROSS L, Jochheim D, Nitschke T, Baquet M, et al
    Platelet Reactivity and Early Outcomes after Transfemoral Aortic Valve Implantation.
    Thromb Haemost. 2018;118:1832-1838.
    PubMed     Abstract available

    August 2018
  24. KARHAUSEN JA, Qi W, Smeltz AM, Li YJ, et al
    Genome-Wide Association Study Links Receptor Tyrosine Kinase Inhibitor Sprouty 2 to Thrombocytopenia after Coronary Artery Bypass Surgery.
    Thromb Haemost. 2018 Aug 13. doi: 10.1055/s-0038-1667199.
    PubMed     Abstract available

    Life-Saving Therapy versus Symptom Relief: Anti-Platelet Agents and Opioids in Coronary Intervention.
    Thromb Haemost. 2018;118:1350-1351.

    June 2018
  26. SUMAYA W, Parker WAE, Fretwell R, Hall IR, et al
    Pharmacodynamic Effects of a 6-Hour Regimen of Enoxaparin in Patients Undergoing Primary Percutaneous Coronary Intervention (PENNY PCI Study).
    Thromb Haemost. 2018 Jun 6. doi: 10.1055/s-0038-1657768.
    PubMed     Abstract available

  27. ALEXOPOULOS D, Xenogiannis I, Vlachakis P, Tantry U, et al
    Peri-Procedural Platelet Reactivity in Percutaneous Coronary Intervention.
    Thromb Haemost. 2018 Jun 4. doi: 10.1055/s-0038-1649484.
    PubMed     Abstract available

  28. WILLEMSEN L, Ten Berg J
    Platelet Inhibition and Bleeding Risks in Patients Undergoing Non-Cardiac Surgery.
    Thromb Haemost. 2018;118:953-955.

    April 2018
  29. MAHLA E, Metzler H, Bornemann-Cimenti H, Prueller F, et al
    Platelet Inhibition and Bleeding in Patients Undergoing Non-Cardiac Surgery-The BIANCA Observational Study.
    Thromb Haemost. 2018 Apr 6. doi: 10.1055/s-0038-1641153.
    PubMed     Abstract available

  30. BOURGUIGNON T, Bernard A, Fauchier L
    Risk of Thromboembolic Events without Oral Anticoagulation at 90 Days after Surgical Aortic Valve Replacement with a Bioprosthesis.
    Thromb Haemost. 2018 Apr 4. doi: 10.1055/s-0038-1641167.

    March 2018
  31. KIBLER M, Marchandot B, Messas N, Caspar T, et al
    CT-ADP Point-of-Care Assay Predicts 30-Day Paravalvular Aortic Regurgitation and Bleeding Events following Transcatheter Aortic Valve Replacement.
    Thromb Haemost. 2018 Mar 28. doi: 10.1055/s-0038-1639352.
    PubMed     Abstract available

    February 2018
  32. DE CARVALHO LP, Fong A, Troughton R, Yan BP, et al
    Prognostic Implications of Dual Platelet Reactivity Testing in Acute Coronary Syndrome.
    Thromb Haemost. 2018;118:415-426.
    PubMed     Abstract available

  33. BIANCARI F, Tauriainen T, Kinnunen EM, Airaksinen J, et al
    External Validation of the WILL-BLEED Risk Score.
    Thromb Haemost. 2018;118:433-434.

    January 2018
  34. PAWLITSCHEK F, Keyl C, Zieger B, Budde U, et al
    Alteration of von Willebrand Factor after Transcatheter Aortic Valve Replacement in the Absence of Paravalvular Regurgitation.
    Thromb Haemost. 2018;118:103-111.
    PubMed     Abstract available

    December 2017
  35. HEWING B, Ellerbroek R, Au SC, Stangl V, et al
    Levels of Circulating Intermediate Monocytes Decrease after Aortic Valve Replacement in Patients with Severe Aortic Stenosis.
    Thromb Haemost. 2017;117:2346-2355.

    February 2017
  36. BIANCARI F, Brascia D, Onorati F, Reichart D, et al
    Prediction of severe bleeding after coronary surgery: the WILL-BLEED Risk Score.
    Thromb Haemost. 2017;117:445-456.
    PubMed     Abstract available

  37. URBANSKI K, Ludew D, Filip G, Filip M, et al
    CD14+CD16++ "nonclassical" monocytes are associated with endothelial dysfunction in patients with coronary artery disease.
    Thromb Haemost. 2017 Feb 23. doi: 10.1160/TH16-08-0614.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Thoracic Surgery is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.